A case of acute eosinophilic pneumonia probably induced by daptomycin
Naomi Kagawa Gakuya Tamagaki Yukari Sugiyama Naoki Ijiri Hiroshi Kamoi Kazuto Hirata
Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University
Here we report the first case in Japan of acute eosinophilic pneumonia that was probably induced by daptomycin. A 61-year-old man had been hospitalized for debridement of a diabetic foot ulcer and was treated by daptomycin because methicillin-resistant Staphylococcus aureus was detected in his wound. Fourteen days after daptomycin treatment was initiated, he developed a high fever, cough, and dyspnea. Chest X-ray and chest CT showed bilateral ground-glass opacities and minimal pleural effusion. Laboratory examinations showed a marked increase in the percentage of eosinophils in peripheral blood and bronchoalveolar lavage fluid. With the diagnosis of daptomysin-induced acute eosinophilic pneumonia, daptomycin treatment was discontinued, and he was treated with prednisolone. Immediately after initiation of the therapy, clinical symptoms improved, and chest X-rays became clear. To the best of our knowledge, this is the first report of acute eosinophilic pneumonia probably induced by daptomycin in Japan.
Daptomycin Drug-induced lung disease Acute eosinophilic pneumonia (AEP) Drug-induced lymphocyte stimulation test (DLST)
Received 27 Aug 2012 / Accepted 2 Nov 2012
AJRS, 2(3): 284-288, 2013